ArticleCurrent oncology (Toronto, Ont.)2020

Willingness of women with early estrogen receptor-positive breast cancer to take adjuvant CDK4/6 inhibitors.

N J Lipton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.